| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 08/26/2008 | CA2304645C Aromatic-substituted xanthene dyes |
| 08/21/2008 | WO2008101247A2 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity |
| 08/21/2008 | WO2008100867A2 Novel inhibitors hepatitis c virus replication |
| 08/21/2008 | WO2008099074A1 Phenyl- (4-phenyl-pyrimidin-2-yl) - amine derivatives as ikk inhibitors, preparation thereof, and pharmaceutical compositions thereof |
| 08/21/2008 | WO2008099073A1 N, n' -2, 4-dianilinopyrimidines preparation and use thereof as ikk inhibitors preparation and teh pharmacuetical compositions thereof |
| 08/21/2008 | WO2008099019A1 6-hydroxy-dibenzodiazepinones useful as hepatitis c virus inhibitors |
| 08/21/2008 | WO2008098978A2 Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor |
| 08/21/2008 | US20080200703 Heterogeneous Ruthenium Catalyst and Method For Hydrogenating a Carboxylic Aromatic Group, in Particular For Producing Core Hydrogenated Bisglycidyl Ether Bisphenols A and F |
| 08/21/2008 | US20080200659 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold |
| 08/21/2008 | CA2679849A1 Functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2678036A1 Functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2676906A1 Novel inhibitors hepatitis c virus replication |
| 08/21/2008 | CA2674087A1 6' substituted compounds having 5-ht6 receptor affinity |
| 08/21/2008 | CA2673532A1 New phenyl-(4-phenyl-pyrimidin-2-yl)-amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 08/21/2008 | CA2672959A1 New n, n'- 2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors |
| 08/20/2008 | EP1958945A1 Compound having hydrocoumarin skeleton, liquid crystal composition and liquid crystal display element |
| 08/20/2008 | EP1957464A1 INDAZOLE DERIVATIVES THAT INHIBIT TRPVl RECEPTOR |
| 08/20/2008 | EP1957457A1 Oxime ester photoinitiators |
| 08/20/2008 | EP1678130B1 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds |
| 08/20/2008 | CN101248156A Novel materials for organic electroluminescent devices |
| 08/20/2008 | CN101248056A Non-steroidal progesterone receptor modulators |
| 08/20/2008 | CN101248046A Amide derivatives as kinase inhibitors |
| 08/20/2008 | CN101245058A Inhibitors of aspartyl protease |
| 08/19/2008 | US7414114 Removing organic or inorganic solvent and water from solution comprising hydrated compound; increased stability |
| 08/19/2008 | US7414073 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/14/2008 | US20080194522 Substituted benzopyran-2-ones; competitive binding ligands for MAO inhibition; anxiolytic agents; neurodegenerative diseases, nervous system disorders; drug screening by comparing detectable changes in fluorescence when samples are oxidatively deaminated in the presence of a MAO |
| 08/14/2008 | US20080194465 Cross-linked glycopeptide-cephalosporin antibiotics |
| 08/14/2008 | US20080194464 Chemical intermediate thereto; effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |
| 08/14/2008 | US20080193682 Electrooptic display |
| 08/13/2008 | EP1956016A1 Bicyclic acyltryptophanols |
| 08/13/2008 | EP1954687A2 Adducts of levulinic derivatives with epoxidized fatty acid esters and uses thereof |
| 08/13/2008 | EP1954678A1 Novel nk1 and nk2 antagonists |
| 08/12/2008 | US7411076 such as 2-chloro-N-(7-hydroxy-2-oxo-2H-1-benzopyran-3-yl)benzamide, used for intensifying the effects of cancer therapy based on DNA injury; protein kinase inhibitors; side effect reduction |
| 08/12/2008 | US7410998 Inhibitors of NADH:ubiquinone oxidoreductase |
| 08/12/2008 | US7410997 relaxing action of tracheal smooth muscles, inhibition of airway hypersensitivity and inhibition of infiltration of inflammatory cells into the airway; useful as antiasthmatic drugs |
| 08/07/2008 | WO2008093853A1 Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same |
| 08/07/2008 | WO2008092491A1 Chroman compounds for use as components in liquid-crystalline media, for example in electrooptical display elements |
| 08/07/2008 | WO2008074413A3 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase |
| 08/07/2008 | US20080188651 Analogs of dictyostatin, intermediates therefor and methods of systhesis thereof |
| 08/07/2008 | US20080188527 Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer |
| 08/07/2008 | US20080188423 Pi-3 kinase inhibitor prodrugs |
| 08/07/2008 | US20080187865 Having aryl ketone methoxy functionality; reduced line edge roughness |
| 08/07/2008 | DE102008004891A1 Chromanverbindungen Chroman |
| 08/07/2008 | CA2673734A1 Macrolide compound in solid form, process for preparation thereof, and pharmaceutical composition containing the same |
| 08/06/2008 | EP1951726A2 Method for the preparation of escitalopram |
| 08/06/2008 | CN101235032A Compound and preparation method thereof |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408570C EP4 receptor antagonists |
| 08/05/2008 | US7408077 Permanent surface modifiers |
| 08/05/2008 | US7407975 Epothilone derivatives, method for producing same and their pharmaceutical use |
| 07/31/2008 | WO2008090357A2 N, n; -substituted piperazines binding to melanocortin receptor |
| 07/31/2008 | WO2008036216A8 Piperidine derivatives as renin inhibitors |
| 07/31/2008 | WO2008023283A3 Stabilized esters of lutein |
| 07/31/2008 | US20080182876 Histamine H3-Receptor Ligands and Their Therapeutic Application |
| 07/31/2008 | US20080182839 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives |
| 07/30/2008 | CN101230034A Nitrogen hetero-cycle compounds for use in the treatment of 5-hydroxide tryptamines related diseases |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/29/2008 | US7405310 Non-nucleoside reverse transcriptase inhibitors |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2256022C 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 07/24/2008 | WO2008087529A1 Nicotinic acetylcholine receptor modulators |
| 07/24/2008 | WO2008059339A3 Isoquinoline derivatives as vanilloid receptor modulators |
| 07/24/2008 | US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
| 07/24/2008 | US20080176896 Modulators of cellular adhesion |
| 07/24/2008 | CA2675676A1 Nicotinic acetylcholine receptor modulators |
| 07/23/2008 | CN101228154A Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 07/23/2008 | CN101225084A Dihydropyrimidine compound and use thereof in preparation of medicine treating and preventing virus diseases |
| 07/23/2008 | CN100404544C 9-ketospinosyn derivatives |
| 07/23/2008 | CN100404531C Xylylene imide herbicide |
| 07/22/2008 | US7402687 for treating a variety of central nervous system disorders such as schizophrenia; agonists or partial agonists of the 2C subtype of brain serotonin receptors |
| 07/22/2008 | US7402683 Cinnamic acid amides |
| 07/22/2008 | CA2474511C Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 07/22/2008 | CA2388076C Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 07/17/2008 | WO2008064826A8 Process for preparing nebivolol |
| 07/17/2008 | DE102007001866A1 Spirocyclische Tetronsäure-Derivate Spirocyclic tetronic acid derivatives |
| 07/16/2008 | EP1944305A1 Quinoline derivatives as phosphodiesterase inhibitors |
| 07/16/2008 | EP1944300A2 Prodrugs of aspartyl protease inhibitors |
| 07/16/2008 | EP1942905A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/16/2008 | EP1165551B1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 07/16/2008 | EP1054004B1 Novel pyrimidine-5-carboxamide derivatives |
| 07/16/2008 | CN101222924A Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 07/15/2008 | US7399779 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists |
| 07/15/2008 | CA2480583C Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
| 07/15/2008 | CA2374639C Process for the preparation of fumagillin |
| 07/10/2008 | WO2008081399A2 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 07/10/2008 | US20080167478 high binding affinity to dopamine, serotonin and norepinephrine transport proteins, used as antidepressants, for tratment of drug abuse and Parkinson's disease |
| 07/10/2008 | US20080167433 a one-pot, two-step process of decarboxylation of hydroxycinnamic acids in the presence of basic cataltsts and solvents, then etherification with a halomethyl-oxirane and recovering the glycidyloxystyrene monomers; homopolymer or copolymer coatings having heat, chemical and wear resistance |
| 07/10/2008 | US20080167353 To treat viral infections and tumors; hepadnaviruses, flaviviruses, herpesviruses and human immunodeficiency virus; treating 3TC (L(-)SddC) resistant hepatitis B virus infections; 9-benzo[1,3]dioxol-5-yl-8-benzyloxymethyl-naphtho[1,2-d][1,3]dioxole-7-carboxylic acid benzyl ester |
| 07/10/2008 | CA2669821A1 2-aza-bicyclo[3.1.0]hexane derivatives |
| 07/09/2008 | EP1940800A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 07/09/2008 | CN101215283A Secalonic acid A compound and its preparing method and application in preparing neuron cell protection medicament |
| 07/09/2008 | CN100400534C Aldose reductase inhibitor, preparation method and use thereof |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/08/2008 | US7396828 PI-3 kinase inhibitor prodrugs |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/03/2008 | WO2008079907A1 Compositions and methods for inhibition of the jak pathway |
| 07/03/2008 | US20080161391 Novel curcumin analogues and uses thereof |
| 07/03/2008 | US20080161287 Bicyclic compound, production and use thereof |